SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-005962
Filing Date
2020-01-22
Accepted
2020-01-22 17:00:42
Documents
5
Period of Report
2020-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205553d1_8k.htm 8-K 37621
2 EXHIBIT 10.1 tm205553d1_ex10-1.htm EX-10.1 123889
3 EXHIBIT 10.2 tm205553d1_ex10-2.htm EX-10.2 119974
4 EXHIBIT 10.3 tm205553d1_ex10-3.htm EX-10.3 126293
5 EXHIBIT 10.4 tm205553d1_ex10-4.htm EX-10.4 120872
  Complete submission text file 0001104659-20-005962.txt   530047
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 20539464
SIC: 2834 Pharmaceutical Preparations